Crucell, GSK agree malaria vaccine dealDutch biotechnology firm Crucell said on Tuesday it had agreed with Britain's GlaxoSmithKline to jointly develop a malaria vaccine candidate. The deal is an extension to an earlier programme agreed in October 2003 between Crucell, GSK and Moreā¦ |